封面
市場調查報告書
商品編碼
1667686

2025 年全球藥物輸注系統市場

Drug Infusion Systems Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年藥物注射系統的市場規模將快速成長。預計到 2029 年將以 9.3% 的複合年成長率成長,達到 204.6 億美元。

預測期內的成長歸因於向一次性系統的轉變、慢性病盛行率的上升、門診護理設施的擴大、個人化醫療和劑量最佳化以及居家照護需求的增加。預測期內的主要趨勢包括無線連接和遠端監控、與電子健康記錄(EHR) 的整合、智慧型幫浦技術、個人化醫療和自適應劑量以及微創輸液技術。

預計慢性病發病率的不斷上升將推動未來幾年藥物輸注系統市場的擴張。癌症、糖尿病、心血管疾病和自體免疫疾病等慢性疾病通常需要長期或持續的液體療法。藥物輸注系統為患有這些疾病的患者提供了一種安全、高效和有效的藥物輸送方法。中低收入國家的慢性病盛行率成長速度快於高所得國家。糖尿病是導致腎衰竭、心臟病、中風、失明和下肢截肢的主要原因。 2024 年 2 月,美國美國管制與預防中心 (CDC) 報告稱,患有多種慢性病的美國數量呈上升趨勢,其中 42% 患有兩種或兩種以上的慢性病,​​12% 患有五種或五種以上的慢性病。因此,慢性病發病率的上升正在推動藥物輸注系統市場的成長。

本報告調查了全球藥物注射系統市場,並總結了市場概況和特點、主要趨勢、市場影響因素分析、市場規模趨勢和預測、各個細分市場的詳細分析、地區/主要國家、競爭格局以及主要企業的概況。

目錄

第1章執行摘要

第2章 藥物輸注系統市場:特點

第3章藥物輸注系統市場:趨勢與策略

第 4 章 藥物輸注系統市場:宏觀經濟情境(包括利率、通貨膨脹、地緣政治、COVID-19 及其對市場復甦的影響)

第5章全球藥物輸注系統市場:成長分析與策略分析框架

  • PESTEL 分析:成長推進因素/阻礙要素
  • 最終用戶產業分析
  • 市場成長分析
  • 市場規模趨勢和成長率
  • 市場規模成長預測
  • 總潛在市場 (TAM)

6. 藥物輸注系統市場區隔

  • 市場規模趨勢與預測:按產品類型
  • 合成橡膠注射系統
  • 一次性輸液系統
  • 注射器注射系統
  • 蠕動幫浦
  • 多通道泵浦
  • 病患自控鎮痛 (PCA) 泵
  • 胰島素幫浦
  • 植入式輸液系統
  • 市場規模趨勢與預測:按管理方式
  • 靜脈
  • 皮下
  • 動脈
  • 硬脊膜外麻醉
  • 其他
  • 市場規模趨勢與預測:按應用
  • 腫瘤和化療
  • 糖尿病
  • 止痛藥
  • 營養
  • 孩子們
  • 其他
  • 市場規模趨勢與預測:按最終用戶
  • 醫院
  • 門診手術中心
  • 診斷中心
  • 其他
  • 合成橡膠注射系統子類型的市場規模趨勢及預測
  • 無排氣合成橡膠泵
  • 通風合成橡膠泵
  • 一次性注射系統子類型市場規模趨勢及預測
  • 一次性使用輸液泵
  • 一次性部件輸液器
  • 注射器注射系統子類型的市場規模趨勢及預測
  • 手動注射輸液幫浦
  • 電動注射輸液幫浦
  • 蠕動幫浦亞型市場規模趨勢及預測
  • 單通道蠕動泵
  • 多通道蠕動泵
  • 市場規模趨勢及預測:按多通道幫浦子類型分類
  • 通用多通道泵浦
  • 用於特定治療的多通道泵
  • 市場規模趨勢及預測:依 PCA 泵浦亞型分類
  • 電子PCA泵
  • 機械PCA泵
  • 市場規模趨勢及預測:以胰島素幫浦亞型分類
  • 持續皮下胰島素輸注 (CSII) 泵
  • 貼片胰島素泵
  • 植入式注射系統各亞型市場規模趨勢及預測
  • 用於治療慢性疼痛的植入式泵
  • 植入式化療泵

第 7 章藥物輸注系統市場:區域與國家分析

  • 市場規模趨勢與預測:按地區
  • 市場規模趨勢與預測:依國家

8. 亞太地區藥物輸注系統市場

9. 中國藥物輸注系統市場

第 10 章印度藥物輸注系統市場

第11章日本藥物輸注系統市場

12. 澳洲藥物輸注系統市場

13. 印尼藥物輸注系統市場

第 14 章韓國藥物輸注系統市場

15. 西歐藥物注射系統市場

第16章英國藥物輸注系統市場

17. 德國藥物注射系統市場

18. 法國藥物注射系統市場

19. 義大利藥物注射系統市場

20. 西班牙藥物注射系統市場

21. 東歐藥物注射系統市場

22. 俄羅斯藥物注射系統市場

23. 北美藥物輸注系統市場

第 24 章美國藥物輸注系統市場

25. 加拿大藥物注射系統市場

26. 南美洲藥物注射系統市場

27. 巴西藥物注射系統市場

28. 中東藥物輸注系統市場

29. 非洲藥物注射系統市場

第 30 章藥物輸注系統市場:競爭格局與公司概況

  • 競爭格局
  • 公司簡介
    • Medtronic plc
    • Baxter International Inc.
    • ICU Medical Inc.
    • Becton Dickinson and Company
    • Smiths Group plc

第 31 章藥物輸注系統市場:其他領先與創新企業

  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Halyard Health Inc.
  • Insulet Corporation
  • Zyno Medical Inc.
  • Braun Melsungen AG
  • Flowonix Medical Inc.
  • IRadimed Corporation
  • Moog Inc.
  • Debiotech SA
  • Fresenius SE & Co. KGaA
  • Johnson & Johnson
  • Hospira
  • Alaris Health Systems Inc.
  • B. Braun Melsungen AG

第 32 章。

第 33 章藥物輸注系統市場:主要併購

第 34 章藥物輸注系統市場:最新趨勢

第 35 章藥物輸注系統市場:高潛力國家、細分市場與策略

  • 提供最多新機會的國家
  • 提供最新機會的市場區隔
  • 成長策略

第 36 章 附錄

簡介目錄
Product Code: r24097

Drug infusion systems, classified as medical devices, are instrumental in delivering medications and fluids into a patient's body through a catheter or needle. This method of administration is commonly employed in hospitals, clinics, and various healthcare settings to dispense medications such as pain relievers, antibiotics, chemotherapy drugs, and fluids to patients.

The primary categories of drug infusion systems encompass elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. Elastomeric infusion systems, for instance, are flexible containers designed to provide a consistent rate of medication delivery for short-term infusion therapy. They find application in hospitals, clinics, and home care settings for short-term drug infusion therapy. These systems are versatile, administered through various modes such as intravenous, subcutaneous, arterially, epidurally, and others. They cater to diverse medical applications, including oncology and chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and more. Various end-users, such as hospitals, ambulatory surgical centers, diagnostic centers, and others, utilize elastomeric infusion systems for their respective needs.

The drug infusion systems market research report is one of a series of new reports from The Business Research Company that provides drug infusion systems market statistics, including drug infusion systems industry global market size, regional shares, competitors with a drug infusion systems market share, detailed drug infusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug infusion systems industry. This drug infusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug infusion systems market size has grown strongly in recent years. It will grow from$13.42 billion in 2024 to $14.34 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to shift to electronic infusion devices, increased prevalence of chronic diseases, patient care advancements, home-based infusion therapy, expansion of ambulatory care settings

The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $20.46 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to shift towards disposable systems, rising prevalence of chronic diseases, expansion of ambulatory care facilities, personalized medicine and adaptive dosing, increasing demand for home-based care. Major trends in the forecast period include wireless connectivity and remote monitoring, integration with electronic health records (ehr), smart pump technology, personalized and adaptive dosing, minimally invasive infusion techniques.

The growing prevalence of chronic diseases is anticipated to drive the expansion of the drug infusion system market in the future. Chronic diseases such as cancer, diabetes, cardiovascular disease, and autoimmune disorders frequently necessitate long-term or continuous infusion therapy. Drug infusion systems provide a safe, efficient, and effective means of delivering medication to patients with these conditions. The prevalence of chronic diseases is rising more rapidly in low- and middle-income countries compared to high-income nations. Diabetes, in particular, is a significant contributor to renal failure, heart attacks, strokes, blindness, and lower limb amputations. For example, in February 2024, reports from the Centers for Disease Control and Prevention (CDC), a U.S.-based organization, indicated that an increasing number of Americans are dealing with multiple chronic conditions, with 42% reporting two or more conditions and 12% experiencing five or more. Therefore, the rising prevalence of chronic diseases is driving the growth of the drug infusion system market.

The rise in healthcare expenditure is expected to drive the growth of the drug infusion systems market in the future. Healthcare expenditure refers to the total amount allocated for healthcare goods and services within a specific timeframe, usually a year. As healthcare spending increases, hospitals, clinics, and other healthcare institutions gain more resources to invest in advanced drug infusion systems, resulting in higher demand for these devices. For example, in May 2024, reports from the Office for National Statistics (ONS), a UK-based national statistical institute, indicated that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of only 0.9% in 2022. Therefore, the increase in healthcare expenditure is likely to propel the growth of the drug infusion systems market.

Leading companies in the drug infusion systems market are focusing on developing advanced technologies, such as cloud-based infusion management systems, to improve patient care, enhance accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that enable the monitoring, administration, and tracking of medication infusions via the cloud. For example, in June 2023, Eitan Medical, a U.S.-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system tailored to meet the specific needs of home and specialty infusions. Eitan Insights provides healthcare professionals with real-time data and analytics, allowing them to monitor patients remotely and adjust treatment plans as necessary. This system enhances medication safety by minimizing the risk of errors and improving adherence to prescribed protocols.

Major players in the drug infusion systems market are directing their efforts towards developing innovative products, such as medication delivery systems, to gain a competitive advantage. Medication delivery systems encompass a diverse range of innovative tools and systems designed to enhance the safe, accurate, and efficient administration of medications. For instance, in February 2023, Mindray Medical International Limited, a China-based manufacturer of medical instrumentation, launched the BeneFusion i/u Series Infusion Systems. These systems provide unparalleled accuracy, adaptive customization, and remarkable simplicity, ensuring guaranteed medication safety in various clinical settings. The BolusGUARD motorized syringe loading system with patent-pending automatic clutch technology prevents loading errors, securing every step of the infusion process. The user-friendly interface and intuitive design streamline workflows and enhance the user experience.

In March 2022, Fresenius Kabi, a pharmaceutical company based in Germany, acquired Ivenix Inc. for $240 million. This strategic acquisition aims to expand Fresenius Kabi's portfolio of infusion therapy products and strengthen its position in the infusion system market. The acquisition positions Fresenius Kabi to offer a comprehensive and leading set of premium infusion therapy products for the benefit of patients, customers, and stakeholders. Ivenix, the acquired company, is a medical technology company based in the United States, specializing in the development of infusion systems.

Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

North America was the largest region in the drug infusion systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug infusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug infusion systems market consists of sales of smart pumps, syringe pumps, enteral infusion systems, and topical infusion systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Infusion Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug infusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug infusion systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug infusion systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Elastomeric Infusion System; Disposable Infusion System; Syringe Infusion System; Peristaltic Pump; Multi-Channel Pump; Patient-Controlled Analgesia (PCA) Pump; Insulin Pump; Implantable Infusion System
  • 2) By Route Of Administration: Intravenous; Subcutaneous; Arterial; Epidural; Other Routes Of Administration
  • 3) By Application: Oncology And Chemotherapy; Diabetes; Analgesia; Nutrition; Hematology; Pediatrics; Other Applications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps; Vented Elastomeric Pumps
  • 2) By Disposable Infusion System: Disposable Infusion Pumps; IV Sets With Disposable Components
  • 3) By Syringe Infusion System: Manual Syringe Infusion Pumps; Electric Syringe Infusion Pumps
  • 4) By Peristaltic Pump: Single-Channel Peristaltic Pumps; Multi-Channel Peristaltic Pumps
  • 5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use; Multi-Channel Pumps For Specific Therapies
  • 6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps; Mechanical PCA Pumps
  • 7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps; Patch Insulin Pumps
  • 8) By Implantable Infusion System: Implantable Pumps For Chronic Pain; Implantable Pumps For Chemotherapy
  • Companies Mentioned: Medtronic plc; Baxter International Inc.; ICU Medical Inc.; Becton Dickinson and Company; Smiths Group plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Infusion Systems Market Characteristics

3. Drug Infusion Systems Market Trends And Strategies

4. Drug Infusion Systems Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Drug Infusion Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug Infusion Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug Infusion Systems Market Growth Rate Analysis
  • 5.4. Global Drug Infusion Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug Infusion Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug Infusion Systems Total Addressable Market (TAM)

6. Drug Infusion Systems Market Segmentation

  • 6.1. Global Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Elastomeric Infusion System
  • Disposable Infusion System
  • Syringe Infusion System
  • Peristaltic Pump
  • Multi-Channel Pump
  • Patient-Controlled Analgesia (PCA) Pump
  • Insulin Pump
  • Implantable Infusion System
  • 6.2. Global Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous
  • Subcutaneous
  • Arterial
  • Epidural
  • Other Routes Of Administration
  • 6.3. Global Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology And Chemotherapy
  • Diabetes
  • Analgesia
  • Nutrition
  • Hematology
  • Pediatrics
  • Other Applications
  • 6.4. Global Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Other End Users
  • 6.5. Global Drug Infusion Systems Market, Sub-Segmentation Of Elastomeric Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Vented Elastomeric Pumps
  • Vented Elastomeric Pumps
  • 6.6. Global Drug Infusion Systems Market, Sub-Segmentation Of Disposable Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Infusion Pumps
  • IV Sets With Disposable Components
  • 6.7. Global Drug Infusion Systems Market, Sub-Segmentation Of Syringe Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Syringe Infusion Pumps
  • Electric Syringe Infusion Pumps
  • 6.8. Global Drug Infusion Systems Market, Sub-Segmentation Of Peristaltic Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Channel Peristaltic Pumps
  • Multi-Channel Peristaltic Pumps
  • 6.9. Global Drug Infusion Systems Market, Sub-Segmentation Of Multi-Channel Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Multi-Channel Infusion Pumps For General Use
  • Multi-Channel Pumps For Specific Therapies
  • 6.10. Global Drug Infusion Systems Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic PCA Pumps
  • Mechanical PCA Pumps
  • 6.11. Global Drug Infusion Systems Market, Sub-Segmentation Of Insulin Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Subcutaneous Insulin Infusion (CSII) Pumps
  • Patch Insulin Pumps
  • 6.12. Global Drug Infusion Systems Market, Sub-Segmentation Of Implantable Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Pumps For Chronic Pain
  • Implantable Pumps For Chemotherapy

7. Drug Infusion Systems Market Regional And Country Analysis

  • 7.1. Global Drug Infusion Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug Infusion Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Infusion Systems Market

  • 8.1. Asia-Pacific Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Infusion Systems Market

  • 9.1. China Drug Infusion Systems Market Overview
  • 9.2. China Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Infusion Systems Market

  • 10.1. India Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Infusion Systems Market

  • 11.1. Japan Drug Infusion Systems Market Overview
  • 11.2. Japan Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Infusion Systems Market

  • 12.1. Australia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Infusion Systems Market

  • 13.1. Indonesia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Infusion Systems Market

  • 14.1. South Korea Drug Infusion Systems Market Overview
  • 14.2. South Korea Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Infusion Systems Market

  • 15.1. Western Europe Drug Infusion Systems Market Overview
  • 15.2. Western Europe Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Infusion Systems Market

  • 16.1. UK Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Infusion Systems Market

  • 17.1. Germany Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Infusion Systems Market

  • 18.1. France Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Infusion Systems Market

  • 19.1. Italy Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Infusion Systems Market

  • 20.1. Spain Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Infusion Systems Market

  • 21.1. Eastern Europe Drug Infusion Systems Market Overview
  • 21.2. Eastern Europe Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Infusion Systems Market

  • 22.1. Russia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Infusion Systems Market

  • 23.1. North America Drug Infusion Systems Market Overview
  • 23.2. North America Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Infusion Systems Market

  • 24.1. USA Drug Infusion Systems Market Overview
  • 24.2. USA Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Infusion Systems Market

  • 25.1. Canada Drug Infusion Systems Market Overview
  • 25.2. Canada Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Infusion Systems Market

  • 26.1. South America Drug Infusion Systems Market Overview
  • 26.2. South America Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Infusion Systems Market

  • 27.1. Brazil Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Infusion Systems Market

  • 28.1. Middle East Drug Infusion Systems Market Overview
  • 28.2. Middle East Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Infusion Systems Market

  • 29.1. Africa Drug Infusion Systems Market Overview
  • 29.2. Africa Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Infusion Systems Market Competitive Landscape And Company Profiles

  • 30.1. Drug Infusion Systems Market Competitive Landscape
  • 30.2. Drug Infusion Systems Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. ICU Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Smiths Group plc Overview, Products and Services, Strategy and Financial Analysis

31. Drug Infusion Systems Market Other Major And Innovative Companies

  • 31.1. Tandem Diabetes Care Inc.
  • 31.2. Terumo Corporation
  • 31.3. Halyard Health Inc.
  • 31.4. Insulet Corporation
  • 31.5. Zyno Medical Inc.
  • 31.6. Braun Melsungen AG
  • 31.7. Flowonix Medical Inc.
  • 31.8. IRadimed Corporation
  • 31.9. Moog Inc.
  • 31.10. Debiotech S.A.
  • 31.11. Fresenius SE & Co. KGaA
  • 31.12. Johnson & Johnson
  • 31.13. Hospira
  • 31.14. Alaris Health Systems Inc.
  • 31.15. B. Braun Melsungen AG

32. Global Drug Infusion Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Infusion Systems Market

34. Recent Developments In The Drug Infusion Systems Market

35. Drug Infusion Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Drug Infusion Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug Infusion Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug Infusion Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer